| Literature DB >> 28095910 |
Riham Omar Bakr1, Mona Mohamed El-Naa2, Soumaya Saad Zaghloul3, Mahmoud Mohamed Omar4,5.
Abstract
BACKGROUND: Nymphaea alba L. represents an interesting field of study. Flowers have antioxidant and hepatoprotective effects, rhizomes constituents showed cytotoxic activity against liver cell carcinoma, while several Nymphaea species have been reported for their hepatoprotective effects. Leaves of N. alba have not been studied before. Therefore, in this study, in-depth characterization of the leaf phytoconstituents as well as its antioxidant and hepatoprotective activities have been performed where N. alba leaf extract was evaluated as a possible therapeutic alternative in hepatic disorders.Entities:
Keywords: Ellagitannins; Hepatotoxicity; Inflammation; Nymphaea alba; Oxidative stress; Palmitic acid
Mesh:
Substances:
Year: 2017 PMID: 28095910 PMCID: PMC5240310 DOI: 10.1186/s12906-017-1561-2
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Peak assignments and tentative identification of the major constituents in N. alba AEE by HRESI-MS/MSa in the positive and negative modes
| Peak Number | Tentatively Identified Compound | tRb (min.) | [M-H]−m/zd | Negative Ionization MS/MSc | [M + H]+m/zd | Positive Ionization MS/MS |
|---|---|---|---|---|---|---|
| 1 | HHDPe -hexoside | 1.85 | 481.06 |
| 483.08 |
|
| 2 | Epicatechin derivative | 2.94 | 427.09 |
| ||
| 3 | Ellagitannin derivative | 3.59 | 817.07 |
| 819.09 |
|
| 4 | HHDP-galloyl-ellagic acid | 4.12 | 773.09 |
| ||
| 5 | Ellagic acid | 4.44 | 301.15 |
| 303.1 |
|
| 6 | Isorhamnetin derivative | 5.38 | 386.96 |
| ||
| 7 | Quercetin 3– | 12.73 | 505.07 |
| 507.09 |
|
| 8 | Ellagic rhamnosyl hexoside | 13.27 | 609.17 |
| 611.18 |
|
| 9 | Lagerstannin A (Bis-HHDP-gluconic acid) | 13.40 | 799.06 |
| 801.08 |
|
| 10 | Brevifolin | 13.5 | 247.02 |
| 249.6 |
|
| 11 | Phyllanthusiin U | 13.72 | 924.11 |
| 926.13 |
|
| 12 | Valoneic acid dilactone dimer | 13.81 | 939.02 |
| 941.02 |
|
| 13 | 3,4,8,9,10-Pentahydroxydibenzo[b,d]pyran-6-one | 14.13 | 275.02 |
| 277.03 |
|
| 14 | Luteolin | 14.34 | 285.04 |
| ||
| 15 | Ellagitannin derivative | 14.45 | 931.11 |
| 933.03 |
|
| 16 | Methyl gallate | 14.56 | 183.03 |
| 185.33 |
|
| 17 | Ellagic acid hexoside | 15.54 | 463.05 |
| 465.05 |
|
| 18 | Catechin or epicatechin derivative | 15.83 | 621.07 |
| ||
| 19 | Orientin | 16.3 | 447.02 |
| ||
| 20 | Ellagitannin derivative | 16.63 | 755.07 |
| ||
| 21 | Phyllanthusiin E | 17.04 | 291.04 |
| 293.03 |
|
| 22 | Ellagitannin derivative | 17.17 | 1153.09 |
| ||
| 23 | Phyllanthusiin B isomer | 18.05 | 969.09 |
| ||
| 24 | Castalin derivative | 18.77 | 967.07 |
| 969.08 |
|
| 25 | HHDP-gluconic acid | 19.21 | 497.06 |
| ||
| 26 | Ellagic acid-galloyl hexoside | 20.85 | 613.05 |
| ||
| 27 | Phyllanthusiin B | 21.17 | 969.09 |
| 971.1 |
|
| 28 | Vescalagin or castalagin | 21.28 | 933.06 |
| 935.07 |
|
| 29 | Apigenin | 24.66 | 269.03 |
| ||
| 30 | Phyllanthusiin C | 24.91 | 925.10 |
| 927.11 |
|
| 31 | Corilagin (Galloyl HHDP hexoside) | 25.14 | 633.07 |
| 635.08 |
|
| 32 | Pedunculagin (Bis HHDP-hexoside) | 25.77 | 783.07 |
| 785.08 |
|
| 33 | Castalin | 26.17 | 631.06 |
| 633.07 |
|
| 34 | Phyllanthusiin C derivative | 27.24 | 1217.12 |
| ||
| 35 | Lagerstannin C (Galloyl-HHDP-gluconic acid | 27.33 | 649.1 |
| 651.08 |
|
| 36 | Catechin or epicatechin | 28.29 | 289.12 |
| 291.42 |
|
| 37 | Lagerstannin B (flavogalloyl HHDP-gluconic acid) | 29.82 | 949.11 |
| ||
| 38 | Granatin B(Galloyl-HHDP-DHHDP-hex) | 30.97 | 951.08 |
| 953.08 |
|
| 39 | Dehydrated tergallic C-glucoside | 31.4 | 613.05 |
| 615.06 |
|
| 40 | Cinnamic acid derv. | 31.5 | 329.09 |
| 331.13 |
|
| 41 | Phyllanthusin B derivative | 32.18 | 981.59 |
| ||
| 42 | Valoneic acid dilactone | 32.47 | 469 |
| ||
| 43 | Gallic acid derivative | 32.61 | 198.62 |
| ||
| 44 | Ellagitannin derivative | 33.31 | 907.08 |
| 909.09 |
|
| 45 | Digalloyl ellagic acid | 33.62 | 605.62 |
| 607 |
|
| 46 | Castalgin derivative | 34.51 | 965.09 |
| 967.10 |
|
| 47 | Chebulagic acid | 34.79 | 953.18 |
| 955.19 |
|
| 48 | Ellagic acid pentoside | 38.56 | 433.04 | 291.15 bp 405.17 301.18 275.23 247 229 | 435.15 | 417.19 bp 407.25 399.14 376.35 343.11 325.11 299.19 181.19 |
| 49 | Ellagic acid rhamnosyl | 39.07 | 447.02 |
| 448.98 |
|
| 50 | Geraniin | 40.40 | 951.07 |
| ||
| 51 | Vescalagin derivative | 40.8 | 965.09 |
| 967.10 |
|
| 52 | Galloyl ellagic acid | 41.83 | 453.04 | 301.13 438.34 291.12 247.11 169.13 273.27 | 455.08 |
|
| 53 | Gallic acid | 62.11 | 169.01 |
|
Boldface digits reflects the base peak (100% abundance)
Fragment ions are listed in order of relative abundances
aHigh resolution liquid chromatography coupled with electrospray ionisation mass /mass spectometry
bRetention time
cMass/Mass spectrometry
dMass to charge ratio
eHexahydroxydiphenic acid
Unsaponifiable content in N. alba
| Compound | Percent |
|---|---|
|
| 0.97 |
|
| 0.84 |
|
| 1.11 |
|
| 9.69 |
|
| 1.13 |
|
| 59.59 |
|
| 2.67 |
|
| 18.96 |
| Total hydrocarbons | 94.96 |
| stigmasterol | 1.68 |
| β-sitosterol | 3.35 |
| Total sterols | 5.03 |
| % Unidentified | 0.006 |
Fatty acid composition (%) of N. alba
| Compound | Percent |
|---|---|
| Octanoic (Caprylic) acid, C8:0 | 1.22 |
| Decanoic (Capric) acid, C10:0 | 1.67 |
| Tetradecanoic (Myristic) acid, C14:0 | 1.64 |
| Hexadecanoic (Palmitic) acid, C16:0 | 40.84 |
| Octadecanoic (Stearic) acid, C18 | 1.43 |
| Eicosanoic (Archidic) acid, C20 | 2.51 |
| ∑SFAa | 49.31 |
| cis-9-Hexadecanoic(Palmitoleic) acid, C16:1ω 7 | 8.41 |
| cis-9-Octadecanoic (Oleic) acid, C18:1ω9 | 1.04 |
| ∑MUFAb | 9.45 |
| cis,cis-9,12-Octadecadienoic (Linolenic) acid, C18:3, ω6 | 24.45 |
| All cis-6,12,15-Octadecotrionic (Linoleic) acid, C18:2 ω6 | 16.78 |
| ∑PUFAsc | 41.23 |
| Total unsaturation | 50.68 |
aSaturated fatty acids
bMonounsaturated fatty acids
cPolyunsaturated fatty acids
Effect of N.alba AEE on CCl4-induced changes in the liver function parameters in rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. ALT, AST, total bilirubin, GGT and ALP were measured
| Parameter | Control | CCl4 |
| Silymarin (100 mg/kg) | |
|---|---|---|---|---|---|
| Low Dose (100 mg/kg) | High Dose (200 mg/kg) | ||||
| ALT (U/L)1 | 32.6 ± 3.1 | 88.1 ± 7.3a | 58.4 ± 4b | 41.9 ± 2.6b | 38.1 ± 2.2b |
| AST (U/L)2 | 68.5 ± 3.5 | 139 ± 8.3a | 105.9 ± 4.1b | 82.1 ± 6.1b | 72.5 ± 4.7b |
| Total Bilirubin (mg/dl) | 0.2 ± 0.02 | 1.2 ± 0.1a | 0.5 ± 0.03b | 0.3 ± 0.03b | 0.2 ± 0.02b |
| GGT (U/L)3 | 7.7 ± 0.6 | 35.9 ± 3.3a | 20.8 ± 1.8b | 12.9 ± 1.2b | 12 ± 1.2b |
| ALP (U/L)4 | 278.5 ± 19.1 | 496.5 ± 38.3a | 414.7 ± 10.9b | 346.6 ± 22.8b | 294.2 ± 15.4b |
Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05
1Alanine aminotransferase
2Aspartate aminotransferase
3Gamma glutamyl transpeptidase
4Alkaline phosphatase
Fig. 1The effect of N. alba AEE on the liver content of GSH in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. GSH was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05
Fig. 2The effect of N. alba AEE on the liver SOD activity in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. SOD was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05
Fig. 3The effect of N. alba AEE on the liver CAT activity in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. CAT was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05
Fig. 4The effect of N. alba AEE on the liver TAC in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. TAC was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05
Fig. 5The effect of N. alba AEE on the liver content of MDA in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. MDA was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05
Fig. 6The effect of N. alba AEE on the liver content of TNF-α in CCl4-intoxicated rats. Rats were intoxicated with CCl4 (0.5 ml/kg; I.P.) and treated with N. alba (100 and 200 mg/kg; P.O.) and silymarin (100 mg/kg; P.O.) for 5 days. TNF-α was determined in the liver homogenate. Data are presented as the mean ± SEM, n = 8. aSignificant difference from control group; P < 0.05. bSignificant difference from CCl4 group; P < 0.05
Fig. 7Representative photomicrographs of histopathological examination of the liver. a Liver of control rats (b and c) Liver of rats intoxicated with CCl4 (0.5 ml/kg; P.O.) showing severe feathery degeneration of hepatocytes and lobular necrosis (B) and portal lymphocytic infiltration (c). d Liver of rats intoxicated with CCl4 and treated with N. alba (100 mg/kg; P.O.) showing slight improvement of feathery degeneration of hepatocytes. e Liver of rats intoxicated with CCl4 and treated with N. alba (200 mg/kg; P.O.) showed marked improvement of the histopathological features. f Liver of rats intoxicated with CCl4 and treated with silymarin (100 mg/kg; P.O.)
Fig. 8Representative photomicrographs of immunohistochemical staining of caspase-3. a Liver of control rats, (b) Liver of rats intoxicated with CCl4 (0.5 ml/kg; P.O.), (c) Liver of rats intoxicated with CCl4 and treated with N. alba (100 mg/kg; P.O.), (d) Liver of rats intoxicated with CCl4 and treated with N. alba (200 mg/kg; P.O.), and (e) Liver of rats intoxicated with CCl4 and treated with silymarin (100 mg/kg; P.O.)